Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is highly expressed in prostate cancer cells. PSMA-based imaging and therapy have ...

Q2 2025 Earnings Call Transcript August 4, 2025 Castle Biosciences, Inc. beats earnings expectations. Reported EPS is $0.15, ...

Medical probe steriliser Nanosonics has hit the US regulatory double jackpot, with the FDA approving iterations of its ...